English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

We have shown a crucial role of HMGB1 in chemotherapy-induced peripheral neuropathy (CIPN). To clarify risk factors for CIPN, we retrospectively analyzed the clinical data of cancer patients undergoing oxaliplatin (OHP) treatment, and then studied the underlying mechanisms using a mouse model for CIPN. Analyses of 150 outpatients treated with OHP in Seichokai Fuchu Hospital identified a significant correlation between the severity of CIPN and plasma ALT, a marker of hepatic disorders. In mice, i.p. OHP at 5 mg/kg caused mechanical allodynia, which was prevented by an anti-HMGB1 antibody (AB) or soluble thrombomodulin (TM) capable of inactivating HMGB1. CCl4 (1%, 5 ml/kg, i.p.) or ethanol (25%, 20 ml/kg x 3 for 2 days, p.o.) significantly increased ALT levels and tended to elevate HMGB1 levels in plasma. CCl4 (every 2 days, 3 times) or ethanol (twice a day, 12 times) did not alter nociceptive threshold in naïve mice, but caused remarkable allodynia in the mice treated with OHP at 1 mg/kg, a subeffective dose, which was blocked by AB or TM. Thus, hepatic disorder is considered a risk factor for aggravation of OHP-induced CIPN in humans and mice, where HMGB1 might play a key role. Young Investigator Outstanding Oral Presentation Award Sessions (YIA)

Hepatic disorder is a risk factor for aggravation of oxaliplatin-induced peripheral neuropathy in humans and mice: Possible involvement of HMGB1